World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
73
Citations
23353
World Ranking
19581
National Ranking
9750

Overview

Sunder Mudaliar is affiliated with the University of California, San Diego in the United States. Their research primarily focuses on medicine, with an emphasis on endocrinology, diabetes, and metabolism. They have contributed 41 publications in the field of medicine, specifically including 13 works in endocrinology, diabetes, and metabolism. Other subfields covered in their research include physiology, molecular biology, epidemiology, and genetics.

The scientist's main research topics center on diabetes treatment and management, diabetes management and research, and metabolism related to diabetes and cancer. Additional areas of study include diet and metabolism, dementia and cognitive impairment research, pharmacology and obesity treatment, as well as adipokines, inflammation, and metabolic diseases.

Among recent papers authored or co-authored by Mudaliar are:

  • "Sodium-glucose co-transporter-2 inhibitors in patients with type 2 diabetes: Barriers and solutions for improving uptake in routine clinical practice" (2022, Diabetes Obesity and Metabolism)
  • "Astaxanthin, a natural antioxidant, lowers cholesterol and markers of cardiovascular risk in individuals with prediabetes and dyslipidaemia" (2023, Diabetes Obesity and Metabolism)
  • "SGLT2 Inhibitor-Induced Low-Grade Ketonemia Ameliorates Retinal Hypoxia in Diabetic Retinopathy-A Novel Hypothesis" (2021, The Journal of Clinical Endocrinology & Metabolism)
  • "Sodium-Glucose Cotransporter Type 2 (SGLT-2) Inhibitors and Ketogenesis: the Good and the Bad" (2020, Current Diabetes Reports)
  • "Comparative Effects of Glucose-Lowering Medications on Kidney Outcomes in Type 2 Diabetes" (2023, JAMA Internal Medicine)

Frequent co-authors working with Mudaliar include:

  • Margaret Tiktin
  • Heidi Krause-Steinrauf
  • Silvio E. Inzucchi
  • Elizabeth Burgess
  • Darin E. Olson

The scientist's articles appear in several notable publication venues with multiple contributions in some journals. These include:

  • Diabetes Care (4 publications)
  • Diabetes Obesity and Metabolism (2 publications)
  • Circulation
  • The Journal of Clinical Endocrinology & Metabolism
  • Current Diabetes Reports

Best Publications

  • Acute and chronic effects of insulin on leptin production in humans: Studies in vivo and in vitro.

    Jerzy W Kolaczynski;Mark R Nyce;Robert V Considine;Guenther Boden

  • Effect of naltrexone plus bupropion on weight loss in overweight and obese adults (COR-I): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial

    Frank L Greenway;Ken Fujioka;Raymond A Plodkowski;Sunder Mudaliar

  • Efficacy and safety of the farnesoid X receptor agonist obeticholic acid in patients with type 2 diabetes and nonalcoholic fatty liver disease.

    Sunder Mudaliar;Robert R. Henry;Arun J. Sanyal;Linda Morrow

  • Pioglitazone for Diabetes Prevention in Impaired Glucose Tolerance

    Ralph A. DeFronzo;Devjit Tripathy;Dawn C. Schwenke;Dawn C. Schwenke;Mary Ann Banerji

  • Can a Shift in Fuel Energetics Explain the Beneficial Cardiorenal Outcomes in the EMPA-REG OUTCOME Study? A Unifying Hypothesis

    Sunder Mudaliar;Sindura Alloju;Robert R Henry

  • Long-term safety, tolerability, and weight loss associated with metformin in the diabetes prevention program outcomes study

    George A. Bray;Sharon L. Edelstein;Jill P. Crandall;Vanita R. Aroda

  • Potential role of glycogen synthase kinase-3 in skeletal muscle insulin resistance of type 2 diabetes.

    S E Nikoulina;T P Ciaraldi;S Mudaliar;P Mohideen

  • Continuous subcutaneous insulin infusion and multiple daily injection therapy are equally effective in type 2 diabetes: a randomized, parallel-group, 24-week study.

    Philip Raskin;Bruce W. Bode;Jennifer B. Marks;Irl B. Hirsch

  • New oral therapies for type 2 diabetes mellitus: The glitazones or insulin sensitizers.

    Sunder Mudaliar;Robert R. Henry

  • Insulin aspart (B28 asp-insulin): a fast-acting analog of human insulin: absorption kinetics and action profile compared with regular human insulin in healthy nondiabetic subjects.

    S R Mudaliar;F A Lindberg;M Joyce;P Beerdsen

  • Canagliflozin Lowers Postprandial Glucose and Insulin by Delaying Intestinal Glucose Absorption in Addition to Increasing Urinary Glucose Excretion: Results of a randomized, placebo-controlled study

    David Polidori;Sue Sha;Sunder Mudaliar;Theodore P. Ciaraldi

  • Modulation of Circulating and Adipose Tissue Adiponectin Levels by Antidiabetic Therapy

    Susan A. Phillips;Theodore P. Ciaraldi;Alice P.S. Kong;Rahil Bandukwala

  • Hyperglycemia associated with pasireotide: results from a mechanistic study in healthy volunteers.

    Robert R. Henry;Theodore P. Ciaraldi;Theodore P. Ciaraldi;Debra Armstrong;Paivi Burke

  • Effect of the dual peroxisome proliferator-activated receptor-α/γ agonist aleglitazar on risk of cardiovascular disease in patients with type 2 diabetes (SYNCHRONY): a phase II, randomised, dose-ranging study

    Robert R Henry;A Michael Lincoff;Sunder Mudaliar;Michael Rabbia

  • Human VEGF gene expression in skeletal muscle: effect of acute normoxic and hypoxic exercise.

    R. S. Richardson;H. Wagner;S. R. D. Mudaliar;R. Henry

  • Exploring the Potential of the SGLT2 Inhibitor Dapagliflozin in Type 1 Diabetes: A Randomized, Double-Blind, Placebo-Controlled Pilot Study

    Robert R Henry;Julio Rosenstock;Steven Edelman;Sunder Mudaliar

  • Thiazolidinediones, peripheral edema, and type 2 diabetes: incidence, pathophysiology, and clinical implications

    Sunder Mudaliar;Anna R Chang;Robert R Henry

  • Differential Effects of Metformin and Troglitazone on Cardiovascular Risk Factors in Patients With Type 2 Diabetes

    Neelima V. Chu;Alice P. S. Kong;Dennis D. Kim;Debra Armstrong

  • Insulin therapy in type 2 diabetes.

    Sunder Mudaliar;Steven V. Edelman;Steven V. Edelman

  • Canagliflozin Lowers Postprandial Glucose and Insulin by Delaying Intestinal Glucose Absorption in Addition to Increasing Urinary

    David Polidori;Sue Sha;Sunder Mudaliar;Theodore P. Ciaraldi

Frequent Co-Authors

Robert R. Henry
Robert R. Henry University of California, San Diego
Ralph A. DeFronzo
Ralph A. DeFronzo The University of Texas Health Science Center at San Antonio
George A. Bray
George A. Bray Louisiana State University
Thomas A. Buchanan
Thomas A. Buchanan University of Southern California
Robert E. Ratner
Robert E. Ratner Georgetown University
Abbas E. Kitabchi
Abbas E. Kitabchi University of Tennessee Health Science Center
Dilip V. Jeste
Dilip V. Jeste University of California, San Diego
Paul Clopton
Paul Clopton Stanford University
Amalia Gastaldelli
Amalia Gastaldelli National Research Council (CNR)
Philip A. Kern
Philip A. Kern University of Kentucky

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Interested in exploring medical careers beyond an MD? There are a variety of online bachelor's in nutrition programs that prepare students for roles in wellness, health promotion, and dietetics. These degrees combine science with practical skills for those who want to have a direct impact on health outside traditional medicine.

For those aiming for healthcare leadership, best online mha programs offer a flexible pathway to working in hospital administration, healthcare policy, or management roles within medical organizations.

Nursing professionals looking to advance can benefit from the rn to bsn online no clinicals accredited programs, which deliver advanced nursing education without traditional hands-on clinical requirements—ideal for working RNs.

If your goal is to reach the highest clinical level, consider the shortest dnp programs online. These options allow qualified nurses to earn a Doctor of Nursing Practice and open doors to leadership, advocacy, and advanced patient care, all in a streamlined format.

These online healthcare degrees can create diverse pathways—both clinical and non-clinical—to impactful medical and health-related careers in the USA.

Best Scientists Citing Sunder Mudaliar

Trending Scientists

Recently Published Articles